Active Government Funding Opportunities

The Army seeks innovative melanoma research proposals to advance understanding of this deadly cancer and improve prevention, detection, and treatment strategies. This program funds early-stage ideas with potential to transform melanoma care and soldier health outcomes.

This Army award supports melanoma survivorship research, focusing on improving quality of life and long-term outcomes for cancer survivors. It seeks studies addressing post-treatment complications, psychosocial factors, and evidence-based interventions for melanoma patients.

Support innovative research into rare melanoma subtypes to advance understanding of disease mechanisms and develop targeted treatment strategies. This Army-sponsored program funds basic and translational research addressing an underexplored cancer area with significant clinical impact.

The Army seeks innovative prostate cancer research to advance detection, prevention, or treatment approaches. This Idea Development Award funds early-stage scientific studies addressing unmet clinical needs in prostate cancer management.

This Army Medical Research funding supports translational research addressing health impacts from toxic exposures on military personnel. Projects bridge discovery science to clinical solutions for affected service members and veterans.

The Army seeks melanoma research to advance understanding and treatment of this serious cancer. This Scholar Award supports innovative scientific studies that could improve patient outcomes and military medical capabilities.

This DOD program funds translational trauma care research that moves promising medical technologies from concept toward real-world solutions. Projects must demonstrate preliminary data and advance casualty survivability and point-of-injury care.

Supports investigator-initiated research advancing bone marrow failure treatments through translational and clinical studies. Funds mature ideas with IND-enabling efforts and correlative research to drive significant patient care improvements.

Seeking early-stage research to develop novel therapies for Duchenne muscular dystrophy across all age groups, from infants to nonambulatory individuals. High-risk/high-reward studies with strong preliminary data that could accelerate near-term clinical outcomes.

The Army seeks patient-centered research to advance burn treatment and recovery outcomes for military personnel. This funding supports innovative clinical studies and therapeutic approaches to improve care for burn-injured soldiers.

The Army seeks innovative technologies and therapeutic approaches to treat severe burn injuries in military personnel. This award funds development of novel burn treatment solutions from basic research through clinical application.

NASA seeks visionary advanced concepts to push the boundaries of space exploration and technology. Phase II awards fund up to two years of development for promising innovations with potential infusion across NASA and beyond.

Support early-career scientists conducting dissertation research on Arctic environmental and social systems change. Funding advances fundamental understanding of rapid Arctic transformation and builds STEM workforce capacity in polar sciences.

DoD seeks applied medical research that translates basic science into near-term clinical solutions for military health problems. Fund up to $3.6M over 4 years for use-inspired research addressing congressionally directed priority topics.

This pilot award funds innovative ovarian cancer research that challenges current thinking and explores novel concepts to drive breakthrough discoveries. Projects must demonstrate exceptional scientific merit and innovative approaches to advance the field.

Support early-career ovarian cancer researchers through an intensive virtual academy offering mentoring, networking, and collaboration. The program develops productive scientists while advancing innovative ovarian cancer research in a structured peer-learning environment.

High-risk, high-reward medical research discovery projects addressing critical DoD health challenges. Pioneering studies generating preliminary data to launch future scientific investigation and product development.

Support early-career clinical trialists developing new ovarian cancer treatments through intensive mentoring, networking, and conducting translational research and early-phase clinical trials.

DoD funds breakthrough breast cancer research advancing toward clinical trials, requiring multidisciplinary teams with consumer advocates. This Level 4 award targets high-impact discoveries ready for human testing and clinical application.

This award funds clinical trials for new ovarian cancer treatments, from early proof-of-concept studies through large-scale efficacy trials. It supports evaluation of drugs, biologics, devices, and emerging technologies to improve patient outcomes.

Support high-impact investigator-initiated research addressing ovarian cancer through basic laboratory to translational studies. Projects must demonstrate strong scientific rationale with preliminary data and potential to advance patient care.

The Army seeks research ideas to advance understanding and countermeasures for tick-borne diseases affecting military readiness. This program supports early-stage scientific investigations to develop novel prevention, diagnosis, or treatment solutions.

This DoD funding supports high-risk, hypothesis-driven research to discover new ALS drugs and therapies. Applications emphasizing novel approaches can succeed without preliminary data, enabling bold therapeutic innovation.

This DoD award supports clinical translational research to advance tuberous sclerosis complex diagnosis, prognosis, and treatments from promising preclinical findings toward real-world clinical application. Multi-PI teams can collaborate on moving TSC research closer to patient care.

This DoD program funds exploratory pancreatic cancer research with a patient-centered focus to develop innovative concepts and generate preliminary data for future clinical applications. Supported research should advance quality of life outcomes through robust studies that avoid preclinical animal work.